Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.
Ralf C. Bargou(Max Delbrück Center), Bernd Dörken(Charité - Universitätsmedizin Berlin)
Cited by 765
Related Papers
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Eight Cycles of Escalated-Dose BEACOPP Compared With Four Cycles of Escalated-Dose BEACOPP Followed by Four Cycles of Baseline-Dose BEACOPP With or Without Radiotherapy in Patients With Advanced-Stage Hodgkin's Lymphoma: Final Analysis of the HD12 Trial of the German Hodgkin Study Group
|Journal of Clinical Oncology|2011|190
In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway
|Blood|2002|100
Combined targeting of <scp>MEK</scp>/<scp>MAPK</scp> and <scp>PI</scp>3<scp>K</scp>/<scp>A</scp>kt signalling in multiple myeloma
|British Journal of Haematology|2012|51
EBAG9 Adds a New Layer of Control on Large Dense-Core Vesicle Exocytosis via Interaction with Snapin
|Molecular Biology of the Cell|2005|41